Procurement Summary
Country : Brazil
Summary : Acquire the Medication of Oral Use Oncolo, for the Benefit of Gap-Co.
Deadline : 16 Apr 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 117142824
Document Ref. No. : 90025/2025
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of Oral Use Gican Oncolo Drugs, for the benefit of GAP -CO.
UASG Code: 120629
Notice from: 02/04/2025 from 08:00 to 11:45 and from 13:30 to 17:00 HS
Proposal Delivery: From 04/02/2025 at 08:00
ABEMACCICIBMg
quantity: 3360
ABEMACICLIB, concentration 150 mg
Quantity: 240
anastrozol, dosage 1 mg
quantity: 1800
apalutamide, concentration 60 mg
quantity: 6480
quantity: 720
axitinib, concentration 5 mg
quantity, concentration 5 mg
quantity: 240
Capecitabine, dosage 500 mg
Quantity: 5040
Degarelix, acetate salt composition, concentration 80 mg, pharmaceutical form Liophile powder for injectable, additional characteristics with application system
quantity: 60
denosumab, concentration 70 mg/ ml, pharmaceutical form injectable
quantity: 40
Denosumab, concentration 70 mg/ml, pharmaceutical form injectable solution
Quantity: 20
enzalutamide, concentration 40 mg
quantity: 6048
enzalutamide, concentration 40 mg
quantity: 672
example, concentration 25 mg
quantity: 1800
gosserrelina acetate, dosage 10.80 mg, indication solutionInjectable
Quantity: 40
gosserrelin acetate, dosage 3.6 mg, indication injectable solution
Quantity: 60
leupro -proiritin acetate, concentration 7.5 mg, pharmaceutical form lipophyl powder for injectable
quantity: 60
leupro -proirline acetate, concentration 22.5 mg, pharmaceutical form
quantity
quantity: 40
leupportine acetate, concentration 45 mg, pharmaceutical form lipyl powder for injectable, additional feature w/ application system
Quantity: 10
pegfilgrastim, concentration 10 mg/ ml, pharmaceutical form injectable solution, added syringe characteristics
quantity:180
Pegfilgrastim, cone ...
Documents
Tender Notice